Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-2807
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer ; day:14 ; month:5 ; year:2019 ; pages:1-12
Pathology & oncology research ; (14.5.2019), 1-12
- Urheber
-
Szentkereszty, Márton
Komlósi, Zsolt István
Szűcs, Gergő
Barna, Gábor
Tamási, Lilla
Losonczy, György
Gálffy, Gabriella
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12253-019-00661-w
- URN
-
urn:nbn:de:101:1-2019062501010953415645
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Szentkereszty, Márton
- Komlósi, Zsolt István
- Szűcs, Gergő
- Barna, Gábor
- Tamási, Lilla
- Losonczy, György
- Gálffy, Gabriella
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sex differences in lymphoid follicles in COPD airways
Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation
Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD
Association between intermediate end points, progression-free survival, and overall survival in first-line advanced or recurrent endometrial cancer
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
First-line management of metastatic non-small cell lung cancer: An Indian perspective
Progression-free sets and rank of matrices
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer
First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint
Sex differences in lymphoid follicles in COPD airways
Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation
Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD
Association between intermediate end points, progression-free survival, and overall survival in first-line advanced or recurrent endometrial cancer
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
First-line management of metastatic non-small cell lung cancer: An Indian perspective
Progression-free sets and rank of matrices
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer
First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint
Sex differences in lymphoid follicles in COPD airways
Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation
Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer
IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD
Association between intermediate end points, progression-free survival, and overall survival in first-line advanced or recurrent endometrial cancer
Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
First-line management of metastatic non-small cell lung cancer: An Indian perspective
Progression-free sets and rank of matrices
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer
First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology